Value-based insurance design for prescription drug coverage increases drug adherence in patients with chronic disease, though their effect on clinical outcomes and health spending remain uncertain.
Braden J. Manns, MD, MSc
Advertisement
Articles by Braden J. Manns, MD, MSc
Advertisement
Latest Updated Articles
- A Systematic Review of Value-Based Insurance Design in Chronic Diseases
Published: October 14th 2014 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Real-World Data Support Dual Benefit of Biologic Therapy for Hidradenitis Suppurativa
2
AI-Driven Research Toolkit Links Aging Biology and Fibrotic Disease
3
Lubiprostone May Offer Renoprotection in CKD
4
FDA Approves CytoCell CDx for Revumenib in KMT2A-Mutant Acute Leukemia
5
